David P. Wilson

The cost-effectiveness of harm reduction

David P. Wilson, David P. Wilson, Braedon Donald et al. · International Journal of Drug Policy · 2014 · 169 citations · Full text

Public Health, Infectious Disease Control, Pharmacoeconomics +17

Coverage Is the Key for Effective Screening of<i>Chlamydia trachomatis</i>in Australia

David G. Regan, David P. Wilson, Jane S. Hocking · The Journal of Infectious Diseases · 2008 · 115 citations · Full text

Medicine, Infectious Disease Control, Infectious Diseases +17

The potential impact of vaccination on the prevalence of gonorrhea

Andrew P. Craig, Richard T. Gray, Jennifer L. Edwards et al. · Vaccine · 2015 · 102 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Frequent Testing of Highly Sexually Active Gay Men is Required to Control Syphilis

Richard T. Gray, Alexander Hoare, Basil Donovan et al. · Sexually Transmitted Diseases · 2010 · 97 citations

Public Health, Infectious Disease Control, Infectious Diseases +17

Estimating the cost-effectiveness of needle-syringe programs in Australia

Jisoo A. Kwon, J. Anderson, Cliff C. Kerr et al. · AIDS · 2012 · 95 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17